title: Emerging therapies for postmenopausal vaginal atrophy.
abstract: Symptoms related to vaginal atrophy are a significant problem for postmenopausal women and estrogen has been the gold standard for its treatment. A number of recent reviews of vaginal estrogen products are available. This review will, therefore, focus on other products and potential products for this indication, including the tissue selective estrogen complex and selective estrogen receptor modulators. Additionally, lesser-studied approaches will be discussed.
authors: Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USA. jhpickar@me.com
authors: James H
authors: JH
authors: Pickar
mesh_terms: D001284:Atrophy; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017698:Postmenopause; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D014621:Vagina / Q000473:pathology*; D014623:Vaginal Diseases / Q000188:drug therapy*
chemical_list: D004967:Estrogens; D020845:Selective Estrogen Receptor Modulators